HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chanel No. 5 Ads To Feature Kidman; Précision Skin Care Products Planned

This article was originally published in The Rose Sheet

Executive Summary

Actress Nicole Kidman has been tapped as the new spokesmodel for Chanel No. 5 and will be featured in global advertising for the fragrance, the French firm said. Print and television ads are slated to break next fall, according to Chanel

You may also be interested in...



Branding, Not Impulse Is Key To Fragrance Success – Kopelman

Fragrance marketers should focus on creating tasteful brands, rather than taking an "impulsive, shotgun approach" to launching new products, former Chanel President and Chief Operating Officer Arie Kopelman said during the Cosmetic, Toiletry and Fragrance Association annual meeting March 2-5 in Boca Raton, Fla

Branding, Not Impulse Is Key To Fragrance Success – Kopelman

Fragrance marketers should focus on creating tasteful brands, rather than taking an "impulsive, shotgun approach" to launching new products, former Chanel President and Chief Operating Officer Arie Kopelman said during the Cosmetic, Toiletry and Fragrance Association annual meeting March 2-5 in Boca Raton, Fla

Celebrity Fragrances Captured 2004 Holiday Season Spotlight

A trend toward celebrity fragrances and scents endorsed by celebrities helped boost fragrance sales in department stores and mass market retail chains during the 2004 holiday season

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011627

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel